Replies to post #283091 on Amarin Corp Plc (AMRN)

[postes]

anfla...exactly!!

If Amarin could just keep suing, the stock wouldn’t have dropped.

[jessellivermore]

anfla...

Sorry but you don't get it..You want to argue off label..but in this case Off label is against the law. The only legal off labeling is for the MARINE label...Off labeling for the R-I indication will be considered Indirect infringement by inducing doctors to prescribe MARINE Generic Vascepa for the R-I (patent protected) indication...

This was spelled out in great detail in the transcripts of DC trial..You need to go back and read them..Medicare will not sanction illegal activity or violating federal law..Actual pharmacists these days mainly work for large corporations and these corporations will definitely tell their pharmacists what the law is...

I don't want to discuss this with you any more..You need to read the trial transcripts.. this infringement issue has been discussed extensively on this board..

":>) JL

[north40000]

Did you look at the Amarin patents relating to CVD treatnebt or the Reduce-It indication? Did you find claim(s) that embrace or comprise or include the Vascepa composition or manufacture within the capsule, with or without the actual capsule also recited in the claim(s)?

Tell JL and me what you found via a message, with copy and paste versions of the claims that you found. If you found no claims comprising a composition of matter or article of manufacture, tell us so. We will stop there for the moment.

I am going to assume you found the kind of claims I asked you to look for. Now I want you to read 35 USC 271(a).

When H enters the market sometime after today, particularly after mid-December 2022 with its generic Vascepa, tell us what you think Amarin will do, hypothetically speaking. How do you think that H escapes any charge of direct infringement in acting to bring its generic Vascepa to market?

[massulo52]

Imo. If the md adds refills to the rx. I think we would have.a chance for infringement